Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU) (EffiDux)

Mobile Health AG

Status: Enrolling

Conditions: Back Pain; Patient Reported Outcome (PRO); Acute Hospitalization; Coughing; Mobile Health Technology (mHealth); Acute Disease; Patient Readmission; Patient Discharge; Mobile Health Apps; Abdominal Pain (AP)

Treatments: Device: Smartphone Application for Post-Discharge Symptom Monitoring

Study type: Interventional

Funder types: Industry

Identifiers

NCT06655337

AAUEffidux

Details and patient eligibility

About

The goal of this clinical trial is to evaluate whether the use of the medidux™ smartphone app can optimize post-discharge management for patients admitted to Acute Admission Units (AAU) with non-urgent health complaints. This trial includes adult patients (age ≥ 18) in Emergency Severity Index (ESI) triage system groups 4 (standard) or 5 (non-urgent), presenting with primary symptoms such as cough, back pain, or abdominal discomfort.

The main question it aims to answer is:

Can the medidux™ app reduce the incidence of AAU readmissions, emergency hospitalizations, or consultations with other medical providers within 7 days after initial admission?

Researchers will compare participants using the medidux™ app (intervention arm) with those receiving standard care (control arm) to observe potential differences in the rates of readmissions, emergency hospitalizations, and medical consultations.

Participants will:

• use the medidux™ app to monitor their symptoms and vital parameters for 7 days after discharge (intervention arm).
• receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions (both arms).

Enrollment: 417 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed Informed Consent Form (ICF)
• Age ≥ 18 years
• (Self-)admission to the involved Acute Admissions Unit (AAU)
• "Lead symptom" identified as coughing, back pain or abdominal discomfort
• Participant within ESI triage system group 4 (standard) and 5 (non-urgent)
• German-speaking
• Ownership of a smartphone or other mobile device with iOS or Android operating system

Exclusion criteria

• Age < 18 years
• Participant whose compliance to the study's protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted
• Participant with insufficient knowledge about the use of a smartphone or other mobile device with iOS or Android operating system
• Participant already using or planning to use another comparable electronic patient-reported symptom monitoring system (e.g. CANKADO) during this trial

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

417 participants in 2 patient groups

Intervention Arm: medidux App

Experimental group

Description:

Participants in this arm will use the medidux™ smartphone application to monitor their symptoms and vital signs for 7 days following discharge from the Acute Admission Unit (AAU). The app provides health monitoring features, prompts for symptom tracking, and guidance on whether further medical consultation is required. Participants will log daily health data and receive automated reminders. The app aims to reduce post-discharge readmissions and emergency hospitalizations by providing real-time support. Follow-up assessments will be conducted at day 7 and day 28 post-discharge to evaluate symptom progression and healthcare utilization.

Treatment:

Device: Smartphone Application for Post-Discharge Symptom Monitoring

Control Arm: Standard Post-Discharge Care

No Intervention group

Description:

Participants in this arm will receive standard post-discharge care as currently practiced in the Acute Admission Unit (AAU). This may include follow-up calls or appointments with healthcare providers to monitor symptoms and progression after discharge, but participants will not use the medidux™ app for symptom tracking or monitoring. Follow-up assessments will be conducted at day 7 and day 28 post-discharge to evaluate symptom progression and healthcare utilization.